Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiromic Biopharma (KRBP)
OTHER OTC:KRBP
RESEARCH TOOLSreports
Kiromic Biopharma (KRBP) Stock Price & Analysis
19 Followers
KRBP Stock Chart & Stats
Day’s Range$2.64 - $2.95
52-Week Range― - ―
Previous Close$2.64
Volume4.00
Average Volume (3M)N/A
Market Cap
$3.40M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 10, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kiromic Biopharma News
PremiumCompany Announcements
Kiromic Biopharma Outlines Vision in Stakeholder Meetings
PremiumCompany Announcements
Kiromic Biopharma Strikes $2M Convertible Debt Deal for Growth
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KRBP FAQ
What was Kiromic Biopharma’s price range in the past 12 months?
Currently, no data Available
What is Kiromic Biopharma’s market cap?
Currently, no data Available
When is Kiromic Biopharma’s upcoming earnings report date?
Kiromic Biopharma’s upcoming earnings report date is May 10, 2024 which is in 13 days.
How were Kiromic Biopharma’s earnings last quarter?
Kiromic Biopharma released its earnings results on May 12, 2023. The company reported -$6.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.17.
Is Kiromic Biopharma overvalued?
According to Wall Street analysts Kiromic Biopharma’s price is currently Overvalued.
Does Kiromic Biopharma pay dividends?
Kiromic Biopharma does not currently pay dividends.
What is Kiromic Biopharma’s EPS estimate?
Kiromic Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kiromic Biopharma have?
Currently, no data Available
What happened to Kiromic Biopharma’s price movement after its last earnings report?
Kiromic Biopharma reported an EPS of -$6.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.275%.
Which hedge fund is a major shareholder of Kiromic Biopharma?
Currently, no hedge funds are holding shares in KRBP
---
Kiromic Biopharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.68%
Trailing 12-Months
Company Description
Kiromic Biopharma
Kiromic BioPharma Inc is a bio-technology company. The company is a gene editing which utilizes artificial intelligence and proprietary neural network platform with a therapeutic focus on immuno-oncology.
---
Technical Analysis
RAPT Therapeutics
―
Arvinas Holding Company
―
Bioxcel Therapeutics
―
Crinetics Pharmaceuticals
―
---